United States Biotechnology & Medical Research

Novavax Inc (NVAX)

Track

Novavax Inc. experienced one notable insider transaction over the past ninety days, involving a proposed sale valued at approximately 235,412 USD by a former officer. This activity occurs amidst a 16.3% decline in share price. The company recently reported results exceeding expectations, though market performance remains volatile within its fifty-two-week range.
Ticker: NVAX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Novavax Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ruxandra Draghia Akli Former Officer Officer
Transaction date
Proposed sale
Price
60.17
Quantity 63,265
Value US$2,807,943
Ruxandra Draghia Akli Former Officer Officer
Transaction date
Proposed sale
Price
479.22
Quantity 62,791
Value US$4,570,044
3.0
YOUNG JAMES F Former Director Non-Executive Director
Transaction date
Proposed sale
Price
224.50
Quantity 94,854
Value US$775,904
3.0
YOUNG JAMES F Former Director Non-Executive Director
Transaction date
Proposed sale
Price
6.10
Quantity 4,000
Value US$24,406
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
8.00
Quantity 5,400 -9.4%
Value US$43,200
3.0
YOUNG JAMES F Director Non-Executive Director
Transaction date
Proposed sale
Price
8.48
Quantity 10,000
Value US$84,800
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
8.48
Quantity 4,600 -7.4%
Value US$39,008
3.0
YOUNG JAMES F Director Non-Executive Director
Transaction date
Proposed sale
Price
8.48
Quantity 10,000
Value US$84,800
2.3
King Rachel K. Non-Executive Director
Transaction date
Sale
Price
9.02
Quantity 4,150 -21.9%
Value US$37,435
2.3
Rachel K. King Board Member
Transaction date
Proposed sale
Price
9.00
Quantity 4,150
Value US$37,350
2.6
Dubovsky Filip Officer Officer
Transaction date
Proposed sale
Price
13.00
Quantity 7,335
Value US$95,331
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
14.09
Quantity 7,500 -10.8%
Value US$105,675
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
14.28
Quantity 1,107 -1.6%
Value US$15,808
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
13.62
Quantity 6,393 -8.3%
Value US$87,073
3.0
YOUNG JAMES F Director Non-Executive Director
Transaction date
Proposed sale
Price
13.71
Quantity 15,000
Value US$205,650
2.6
Dubovsky Filip President, R&D Officer
Transaction date
Sale
Price
14.54
Quantity 1,404 -2.1%
Value US$20,414
2.6
Dubovsky Filip President, R&D Officer
Transaction date
Sale
Price
14.46
Quantity 12,500 -15.5%
Value US$180,750
2.6
Dubovsky Filip Officer Officer
Transaction date
Proposed sale
Price
14.47
Quantity 13,904
Value US$201,185
2.6
Dubovsky Filip President, R&D Officer
Transaction date
Sale
Price
13.90
Quantity 47,312 -54.8%
Value US$657,637
2.6
Dubovsky Filip Officer Officer
Transaction date
Proposed sale
Price
13.89
Quantity 47,312
Value US$657,386
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Purchase
Price
6.50
Quantity 1,000 +7.4%
Value US$6,500
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Purchase
Price
7.04
Quantity 2,000 +17.4%
Value US$14,088
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned purchase
Price
7.48
Quantity 3,000 +35.4%
Value US$22,454
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
75.10
Quantity 300 -0.5%
Value US$22,531
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
74.25
Quantity 3,255 -4.9%
Value US$241,684
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
73.29
Quantity 8,945 -11.9%
Value US$655,550
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
144.43
Quantity 100 -2.5%
Value US$14,443
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
143.64
Quantity 1,003 -20.3%
Value US$144,070
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
142.65
Quantity 800 -13.9%
Value US$114,117
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
141.69
Quantity 800 -12.2%
Value US$113,350
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
140.05
Quantity 500 -7.1%
Value US$70,026
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
139.08
Quantity 997 -12.4%
Value US$138,660
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
137.85
Quantity 400 -4.7%
Value US$55,140
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
136.82
Quantity 400 -4.5%
Value US$54,728
3.0
YOUNG JAMES F Non-Executive Director
Transaction date
Sale
Price
144.16
Quantity 3,750 -4.8%
Value US$540,601
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
230.00
Quantity 5,000 -56.5%
Value US$1,150,000
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
180.62
Quantity 27 -0.5%
Value US$4,877
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
179.58
Quantity 206 -3.5%
Value US$36,993
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
178.99
Quantity 103 -1.7%
Value US$18,436
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
176.83
Quantity 223 -3.6%
Value US$39,432
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
175.89
Quantity 67 -1.1%
Value US$11,785
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
174.65
Quantity 137 -2.1%
Value US$23,927
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
173.29
Quantity 91 -1.4%
Value US$15,770
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
172.38
Quantity 248 -3.7%
Value US$42,750
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
171.47
Quantity 254 -3.6%
Value US$43,553
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
170.46
Quantity 213 -2.9%
Value US$36,309
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
168.82
Quantity 117 -1.6%
Value US$19,752
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
182.96
Quantity 100 -2.4%
Value US$18,296
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
182.30
Quantity 853 -17.0%
Value US$155,498
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
180.29
Quantity 500 -9.1%
Value US$90,147
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
179.36
Quantity 500 -8.3%
Value US$89,680
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
178.21
Quantity 500 -7.7%
Value US$89,104
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
176.20
Quantity 800 -10.9%
Value US$140,956
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
175.13
Quantity 900 -11.0%
Value US$157,619
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
173.14
Quantity 200 -2.4%
Value US$34,627
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
171.30
Quantity 200 -2.3%
Value US$34,260
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
168.77
Quantity 400 -4.4%
Value US$67,508
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
167.06
Quantity 300 -3.2%
Value US$50,118
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
165.80
Quantity 300 -3.1%
Value US$49,739
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
164.77
Quantity 300 -3.0%
Value US$49,430
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
162.83
Quantity 200 -2.0%
Value US$32,565
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
161.63
Quantity 300 -2.9%
Value US$48,490
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
160.52
Quantity 300 -2.8%
Value US$48,157
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
158.42
Quantity 300 -2.7%
Value US$47,527
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
157.02
Quantity 200 -1.8%
Value US$31,404
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
156.24
Quantity 300 -2.6%
Value US$46,873
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
154.38
Quantity 100 -0.9%
Value US$15,438
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
153.53
Quantity 397 -3.3%
Value US$60,951
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
151.85
Quantity 100 -0.8%
Value US$15,185
2.9
Glenn Gregory M President, R&D Officer
Transaction date
Planned sale
Price
150.30
Quantity 200 -1.6%
Value US$30,059
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
202.36
Quantity 366 -11.7%
Value US$74,064
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
200.92
Quantity 300 -8.8%
Value US$60,276
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
199.81
Quantity 300 -8.1%
Value US$59,944
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
198.35
Quantity 400 -9.7%
Value US$79,340
3.5
Herrmann John A III EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
197.19
Quantity 300 -6.8%
Value US$59,156
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-27 2026-05-27 PrS Proposed sale
Ruxandra Draghia Akli

Former Officer

Officer
63,265
60.17
US$2,807,943 		63,265 60.17 US$2,807,943
2026-05-07 2026-05-07 PrS Proposed sale
Ruxandra Draghia Akli

Former Officer

Officer
62,791
479.22
US$4,570,044 		62,791 479.22 US$4,570,044
2025-05-19 2025-05-19 PrS Proposed sale
3.0
YOUNG JAMES F

Former Director

Non-Executive Director
94,854
224.50
US$775,904 		94,854 224.50 US$775,904
2025-04-14 2025-04-14 PrS Proposed sale
3.0
YOUNG JAMES F

Former Director

Non-Executive Director
4,000
6.10
US$24,406 		4,000 6.10 US$24,406
2025-01-02 2024-12-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
5,400 -9.4%
8.00
US$43,200 		5,400 -9.4% 8.00 US$43,200
2025-01-02 2024-12-24 PrS Proposed sale
3.0
YOUNG JAMES F

Director

Non-Executive Director
10,000
8.48
US$84,800 		10,000 8.48 US$84,800
2025-01-02 2024-12-24 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
4,600 -7.4%
8.48
US$39,008 		4,600 -7.4% 8.48 US$39,008
2024-12-26 2024-12-24 PrS Proposed sale
3.0
YOUNG JAMES F

Director

Non-Executive Director
10,000
8.48
US$84,800 		10,000 8.48 US$84,800
2025-01-02 2024-12-13 S Sale
2.3
King Rachel K.
Non-Executive Director
4,150 -21.9%
9.02
US$37,435 		4,150 -21.9% 9.02 US$37,435
2024-12-13 2024-12-13 PrS Proposed sale
2.3
Rachel K. King

Board Member
4,150
9.00
US$37,350 		4,150 9.00 US$37,350
2024-09-18 2024-09-18 PrS Proposed sale
2.6
Dubovsky Filip

Officer

Officer
7,335
13.00
US$95,331 		7,335 13.00 US$95,331
2024-06-25 2024-06-21 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
7,500 -10.8%
14.09
US$105,675 		7,500 -10.8% 14.09 US$105,675
2024-06-21 2024-06-18 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
1,107 -1.6%
14.28
US$15,808 		1,107 -1.6% 14.28 US$15,808
2024-06-21 2024-06-18 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
6,393 -8.3%
13.62
US$87,073 		6,393 -8.3% 13.62 US$87,073
2024-06-18 2024-06-18 PrS Proposed sale
3.0
YOUNG JAMES F

Director

Non-Executive Director
15,000
13.71
US$205,650 		15,000 13.71 US$205,650
2024-06-20 2024-06-17 S Sale
2.6
Dubovsky Filip

President, R&D

Officer
1,404 -2.1%
14.54
US$20,414 		1,404 -2.1% 14.54 US$20,414
2024-06-20 2024-06-17 S Sale
2.6
Dubovsky Filip

President, R&D

Officer
12,500 -15.5%
14.46
US$180,750 		12,500 -15.5% 14.46 US$180,750
2024-06-17 2024-06-17 PrS Proposed sale
2.6
Dubovsky Filip

Officer

Officer
13,904
14.47
US$201,185 		13,904 14.47 US$201,185
2024-05-15 2024-05-14 S Sale
2.6
Dubovsky Filip

President, R&D

Officer
47,312 -54.8%
13.90
US$657,637 		47,312 -54.8% 13.90 US$657,637
2024-05-14 2024-05-14 PrS Proposed sale
2.6
Dubovsky Filip

Officer

Officer
47,312
13.89
US$657,386 		47,312 13.89 US$657,386
2023-03-14 2023-03-10 B Purchase
2.9
Glenn Gregory M

President, R&D

Officer
1,000 +7.4%
6.50
US$6,500 		1,000 +7.4% 6.50 US$6,500
2023-03-14 2023-03-07 B Purchase
2.9
Glenn Gregory M

President, R&D

Officer
2,000 +17.4%
7.04
US$14,088 		2,000 +17.4% 7.04 US$14,088
2023-03-14 2023-03-06 PP Planned purchase
2.9
Glenn Gregory M

President, R&D

Officer
3,000 +35.4%
7.48
US$22,454 		3,000 +35.4% 7.48 US$22,454
2022-04-04 2022-03-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
300 -0.5%
75.10
US$22,531 		300 -0.5% 75.10 US$22,531
2022-04-04 2022-03-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
3,255 -4.9%
74.25
US$241,684 		3,255 -4.9% 74.25 US$241,684
2022-04-04 2022-03-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
8,945 -11.9%
73.29
US$655,550 		8,945 -11.9% 73.29 US$655,550
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
100 -2.5%
144.43
US$14,443 		100 -2.5% 144.43 US$14,443
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
1,003 -20.3%
143.64
US$144,070 		1,003 -20.3% 143.64 US$144,070
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
800 -13.9%
142.65
US$114,117 		800 -13.9% 142.65 US$114,117
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
800 -12.2%
141.69
US$113,350 		800 -12.2% 141.69 US$113,350
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
500 -7.1%
140.05
US$70,026 		500 -7.1% 140.05 US$70,026
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
997 -12.4%
139.08
US$138,660 		997 -12.4% 139.08 US$138,660
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
400 -4.7%
137.85
US$55,140 		400 -4.7% 137.85 US$55,140
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
400 -4.5%
136.82
US$54,728 		400 -4.5% 136.82 US$54,728
2022-01-04 2021-12-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
3,750 -4.8%
144.16
US$540,601 		3,750 -4.8% 144.16 US$540,601
2021-12-22 2021-12-20 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
5,000 -56.5%
230.00
US$1,150,000 		5,000 -56.5% 230.00 US$1,150,000
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
27 -0.5%
180.62
US$4,877 		27 -0.5% 180.62 US$4,877
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
206 -3.5%
179.58
US$36,993 		206 -3.5% 179.58 US$36,993
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
103 -1.7%
178.99
US$18,436 		103 -1.7% 178.99 US$18,436
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
223 -3.6%
176.83
US$39,432 		223 -3.6% 176.83 US$39,432
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
67 -1.1%
175.89
US$11,785 		67 -1.1% 175.89 US$11,785
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
137 -2.1%
174.65
US$23,927 		137 -2.1% 174.65 US$23,927
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
91 -1.4%
173.29
US$15,770 		91 -1.4% 173.29 US$15,770
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
248 -3.7%
172.38
US$42,750 		248 -3.7% 172.38 US$42,750
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
254 -3.6%
171.47
US$43,553 		254 -3.6% 171.47 US$43,553
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
213 -2.9%
170.46
US$36,309 		213 -2.9% 170.46 US$36,309
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
117 -1.6%
168.82
US$19,752 		117 -1.6% 168.82 US$19,752
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
100 -2.4%
182.96
US$18,296 		100 -2.4% 182.96 US$18,296
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
853 -17.0%
182.30
US$155,498 		853 -17.0% 182.30 US$155,498
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
500 -9.1%
180.29
US$90,147 		500 -9.1% 180.29 US$90,147
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
500 -8.3%
179.36
US$89,680 		500 -8.3% 179.36 US$89,680
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
500 -7.7%
178.21
US$89,104 		500 -7.7% 178.21 US$89,104
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
800 -10.9%
176.20
US$140,956 		800 -10.9% 176.20 US$140,956
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
900 -11.0%
175.13
US$157,619 		900 -11.0% 175.13 US$157,619
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -2.4%
173.14
US$34,627 		200 -2.4% 173.14 US$34,627
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -2.3%
171.30
US$34,260 		200 -2.3% 171.30 US$34,260
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
400 -4.4%
168.77
US$67,508 		400 -4.4% 168.77 US$67,508
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -3.2%
167.06
US$50,118 		300 -3.2% 167.06 US$50,118
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -3.1%
165.80
US$49,739 		300 -3.1% 165.80 US$49,739
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -3.0%
164.77
US$49,430 		300 -3.0% 164.77 US$49,430
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -2.0%
162.83
US$32,565 		200 -2.0% 162.83 US$32,565
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.9%
161.63
US$48,490 		300 -2.9% 161.63 US$48,490
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.8%
160.52
US$48,157 		300 -2.8% 160.52 US$48,157
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.7%
158.42
US$47,527 		300 -2.7% 158.42 US$47,527
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -1.8%
157.02
US$31,404 		200 -1.8% 157.02 US$31,404
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.6%
156.24
US$46,873 		300 -2.6% 156.24 US$46,873
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
100 -0.9%
154.38
US$15,438 		100 -0.9% 154.38 US$15,438
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
397 -3.3%
153.53
US$60,951 		397 -3.3% 153.53 US$60,951
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
100 -0.8%
151.85
US$15,185 		100 -0.8% 151.85 US$15,185
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -1.6%
150.30
US$30,059 		200 -1.6% 150.30 US$30,059
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
366 -11.7%
202.36
US$74,064 		366 -11.7% 202.36 US$74,064
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
300 -8.8%
200.92
US$60,276 		300 -8.8% 200.92 US$60,276
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
300 -8.1%
199.81
US$59,944 		300 -8.1% 199.81 US$59,944
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
400 -9.7%
198.35
US$79,340 		400 -9.7% 198.35 US$79,340
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
300 -6.8%
197.19
US$59,156 		300 -6.8% 197.19 US$59,156
Explore more

More insider trading research around Novavax Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America